-
Nov 29, 2019 Enrollment of the second cohort in TMS-007 Phase II clinical trial was completed
-
Nov 25, 2019 Method of use patent of SMTP compounds for ischemic damage was issued in US
-
Dec 22, 2015 Our program entitled "Clinical development of TMS-007 as a novel stroke drug" has been granted a fund from The New Energy and Industrial Technology Development Organization (NEDO).
-
Nov 16, 2015 We completed the phase l clinical trial of TMS-007 in October 2015.